Time to try this warfarin alternative?

Abstract

Consider dabigatran, an oral anticoagulant that does not require monitoring, for the prevention of stroke and thromboembolism in patients with atrial fibrillation. Strength of recommendation: B: Based on a single well-done randomized controlled trial (RCT).